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[571 ABSTRACT 
An anti-inflammatory and analgesic composition con- 
taining indomethacin and an H2 histamine receptor an- 
tagonist in an amount sufficient to reduce gastric dis- 
tress caused by the indomethacin. Usable antagonists 
are metiamide and cimetidine. 
2 Claims, 5 Drawing Figures 
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Hz-receptor antagonists such as metiamide and cimeti- 
INDOMETHACIN-ANTIHISTAMINE dine. 
COMBINATION FOR GASTRIC ULCERATION 
CONTROL DESCRIPTION O F  THE DRAWINGS 
5 FIG. 1 of the drawings depicts the ulcerogenic prop- 
erties of indomethacin in the presence and in the ab- 
Sence of stress. 
FIG. 2, provided for comparison purposes, depicts 
the ulcerogenic properties of aspirin under similar con- 
FIG. 3 shows a rat stomach which has been opened 
and spread out to locate the various zones where ulcers 
FIG. 4 illustrates the effect of an Hi receptor antago- 
l5 nist, pyrilamine, on gastric ulceration induced by indo- 
methacin in rats under stress. 
FIG. 5, on the other hand, shows the effect of an H2 
receptor antagonist, metiamide, under similar condi- 
tions. 
ORIGIN O F  THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and is sub- 
ject to the provisions of Section 305 of the National 
Aeronautics and Space Act of 1958, Public Law 85-568 lo ditions. 
(72 Stat. 435; 42 U.S.C. 2457). 
RELATED APPLICATION may be produced. 
This application is a continuation-in-part of Applica- 
tion Ser. No. 850,504, filed on Nov. 10, 1977. 
BACKGROUND O F  THE INVENTION 
1. Field of the Invention 
This invention relates to indomethacin, a relatively 
new compound that has found wide use as an anti-in- 2o 
flammatory agent, an antipyretic and an analgesic. 
More particularly, the invention relates to the the elimi- 
nation of the undesirable gastric side effects caused by 
the compound. 
DETAILED DESCr ~~ ~ 
INVEh 1 i u ~  
Indomethacin, i.e., l-(p-chlorobenzoyl)-5-methoxy-2- 
methyl-3-indolylacetic acid, has found much accep- 
25 tance in pharmaceutical therapy for its anti-inflamma- 2. The Prior Art 
Non-steroidal anti-inflammatory agents, such as =Pi- 
rin and indomethacin, have 10% been known to be 
tory, antipyretic, and analgesic properties. In Some of 
these capacities, the compound may have to be taken 
ulcerogenic, particularly in conjunction with other in- 
fluences, such as stress. One of the most successful ef- 
forts to combat this undesirable side effect of an other- 30 under stress. 
mide with aspirin, disclosed by Brown et al. in "Hista- caused by the ingestion of indomethacin by a subject mine H2 Receptor: Involvement in Gastric Ulceration, under stress can be significantly reduced by administer- 
1976). Interestingly, this compound metiamide, which 35 cimetidine. 
was found to reliably reduce ulceration produced by The indomethacin and the antihistamine may be ad- stress alone, or by a combination of stress and aspirin, is 
known to be an H~ histamine receptor antagonist. On ministered individually or together in the same dosage 
the other hand, H~ receptor antagonists, such a- pyrila- unit, such as tablets, c a p s u h  liquids and so on. Suitable 
mine, a compound which has been heretofore adminis- 40 diluents or even additional active ingredients can be 
ineffective for the control of gastric ulceration. dosage, i.e., about 25 mg to 200 mg daily, while the 
As to indomethacin, attempts to combat the gastroin- dosage for the antihistamine can range from 200 mg to 
tentinal side effects that it induces in a patient have 45 1.5 g daily, as Presently envisioned. 
resulted in the discovery that the undesirable effects can The invention Will now be described in greater opera- 
be controlled by the administration of certain prosta- tional detail by the following examples, which are pro- 
glandin substances (Lippmann, U.S. Pat. NO. 3,927,213) vided to illustrate but not to limit the concepts and the 
and certain amino acids (Takagi et al., U.S. Pat. No. Practices disclosed. 
3,988,466). It should be noted also that indomethacin 50 Female sPrague-DawleY rats weighing between 220 
itself can be used to control, inter alia, the peptic ulcer and 250 g were used in the procedures described in all 
complications often produced by anti-inflammatory the examples. They were housed in a controlled envi- 
adrenocortical steroids (Winter, U.S. pat. No. ronment with lights on each day between 0600 and 1800 
3,46 1,208). hours, and maintained on an ad libitum schedule of food 
55 and water for one week prior to any experiment. 
Twenty-four hours before an experiment, they were 
deprived of food and placed in individual wire cages. 
All drugs administered in the experiments that are the 
subject of the examples were delivered by gastric intu- 
EXAMPLE 1 
This example provides a controlled comparison of 
the gastric ulceration capacity of indomethacin and 
In this experiment, animals were assigned randomly 
either to a stress or a nonstress condition. The stress 
condition applied was a modification of multiple-stress 
for long periods and in large doses, and under such a 
regime, it often gives rise to gastric ulcers in subjects 
wise very has been the use Of metia- It has now been discovered that the gastric ulcers 
" Life Sciences 18, pages 339-344 Press, ing an H2-receptor antagonist, e.g., metiamide and 
tered with aspirin for purposes other than that of pres- 
ent concern, have been found by the Same workers to be 
Present in such Preparations, if desired. In event, 
the anti-inflammatory drug is employed in its usual 
SUMMARY OF THE INVENTION 
It is an object of the present invention to provide 
pharniaceutical preparations containing indomethacin, 
which do not cause gastric distress in a patient subject 
to stress. A more specific object is to provide anti-in- 60 bation in 2 ml of 1% methylcellulose. 
flammatory, antipyretic and analgesic compositions 
containing indomethacin and at least one other com- 
pound which can markedly reduce or eliminate gastric 
ulceration that indomethacin generally causes in pa- 
tients under stress. 
These objects have been accomplished by formulat- 
ing preparations which include indomethacin and an 
antihistamine component consisting of one or more 
65 aspirin, in the presence and in the absence of stress. 
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procedure described by Levine (1967) and entailed indomethacin. Second, the dose-response relation for 
individually restraining rats for two hours in commer- aspirin rises gradually over about a 2 log unit range, 
cially available Plexiglas devices placed in an environ- whereas that for indomethacin rises abruptly over less 
mental chamber maintained at 5" C. [See R. J. Levine, than 1 log unit. 
Peptic Ulcer, (Ed. c. J. pfeiffer), Pages 92-97, Lippin- 5 Since both stress and high doses of aspirin are known 
cott (1971); E. c. SenaY and R. J. Levine, P~LX SOC. to individually elevate the level of corticosteroids and 
ExP. Bid. hfed 124, 1221-1223 (196711. within each since corticosteroids are known to be ulcerogenic, an 
condition, the animals received orally one of several attempt was made to determine whether the ulceration 
doses of aspirin or indomethacin. Thirty minutes after attributed to either indomethacin or aspirin could have 
drug administration, the animals were subjected either 10 been caused in part by an augmented adrenocortical 
to two hours of cold restraint (stress condition) or re- response. 
turned to their home cages (non-stress condition) for the M~~~ plasma corticosterone levels were therefore 
determined on the two-hour blood samples earlier men- same duration of time. 
were tioned and the results of the tests are shown in the fol- sacrificed by decapitation and blood was collected from 15 lowing table. 
the trunk in chilled heparinized tubes and centrifuged. 
The plasma was separated and frozen for subsequent 
At the end Of the two-hour period, the 
TABLE 1 
fluorometric assay of corticosterone [Vernikos-Danellis 
J.  et al. Changes in adrenal corticosterone concentra- 
tion in rats. Method of bioassay for ACTH. Endocrinol- 20 
ogy, 1966, 79, 624-6301. The stomach then was re- Dose 
ture, opened, rinsed with tap water and pinned in a 
standard position for microscopic examination and scor- 
ing of ulcers. Ulcers measuring less than 1 mm were not 25 32.0 f 3.7 134.1 C 5.3 
20 27.3 C 7.2 138.9 I: 4.4 
40 26.9 C 5.0 137.2 k 3.9 
defined as the sum of the maximum continuous lengths 80 137.3 f 7.1 
(in mm) of each ulcer. This scoring method was found 160 126.0 f 9.2 
previously to be highly reliable (Brown et al. 1976). Indomethacin Indomethacin + 
Representative stomachs were fixed in 10% formol 30 Stress (n = 10) 
saline and 8p paraffin sections from tissue blocks taken 0 21.1 & 3.7 134.3 & 5.0 
1.5 23.6 I: 4.9 132.4 +- 5.1 
3.0 21.1 C 5.2 138.5 C 3.9 
eosin and examined microscopically. 6.0 29.0 f 5.9 136.5 f 3.5 
139.4 & 8.7 
EFFECT OF ANTI-INFLAMMATORY AGENTS ON 
MEAN PLASMA CORTICOSTERONE LEVELSu IN 
STRESSED AND NONSTRESSED RATS 
(mg/kg) Experimental condition moved from the animal, cut along the greater curva- 
Aspirin Aspirin + Stress 
(n = 9) (n = 9) 
0 
scored. For each animal, the overall ulcer score was 
34.7 f 5.9 
63.9 I: 7.7 
(n = 10) 
from ulcerated areas were stained with hematoxylin and 
The dosages of aspirin and indomethacin and the 12.0 32.9 C 6.5 
consequences of such dosages are shown in FIGS. 1 and 35 
2 of the drawings. 
As FIG. 2 indicates, there was a dramatic synergism From the table, it can be readily seen that corticoste- 
between aspirin and environmental stress in the produc- rone levels at the end of the two-hour period were 
tion of gastric ulceration. Control stressed animals that markedly elevated in rats under stress. H ~ ~ ~ ~ ~ ~ ,  nei- 
received only the methylcellulose vehicle (zero dose of 40 ther indomethacin nor aspirin produced any significant 
aspirin) essentially did not Ukerate (Ulcers generally additional increase in corticosterone in these animals. 
S.E. ( p g / l ~  ,I of plasma) 
were less than mm) and 
rin to produce 
very high doses Of aspi- 
gastric damage in the 
Thus, increasing gastric damage produced by the drugs 
in the stressed rats was not associated with an increase 
absence of stress. However, in conjunction with stress, in circulating corticosterone. The mean corticosterone 
the administration of low doses (2.5 mg/kg) did result in 45 levels of nonstressed animals were also unaffected by 
mg/kg resulted in substantial ulceration in these animals latter rise in corticosterone was not accompanied by with a mean score of 27.4. Maximum ulceration was 
obtained with 160 mg/kg of aspirin, yielding a mean any corresponding increase in gastric ulceration. 
ulcer score of 56.9. Still higher doses produced no fur- 50 EXAMPLE 2 
ther increase in gastric ulceration. The dose-response 
relationship was highly significant tested with a one- In this example the size and regional distribution of 
way analysis of variance (F=4.88; df=63; p<O.OI). ulceration produced by indomethacin and aspirin are 
Similarly, in the absence of stress, high doses (12 'Ompared. 
mg/kg) of indomethacin failed to produce gastric ulcers 55 
as shown in FIG. 1. However, the lowest dose of indo- to groups receiving either 12 mg/kg of indomethacin or 
methacin administered (1.5 mg/kg) produced apprecia- 20 m d k g  of aspirin. The doses administered were se- 
ble gastric damage in stressed rats. Increasing the dose lected On the basis Of 
to 12 mg/kg resulted in a mean ulcer score of 28.2. Still (FIGS. 1 and 2)  to give approximately the Same mean 
higher doses produced no further increase in ulceration. 60 ulcer score. Thirty minutes after drug administration, 
The dose-response relationship was highly significant as the animals were put in cold restraint for two hours. At 
tested with a one-way analysis of variance (F=7.35; the end of the stress period, the animals were sacrificed 
df=4.45; p<O.Ool). The difference between the maxi- and ulcers were scored a described in Example 1. 
mum ulcer scores produced by indomethacin and aspi- The gastric ulcers produced by aspirin and indometh- 
rin was also significant (p<0.05). 65 acin in stressed rats appeared as black or brown punc- 
The dose-response relations for aspirin and indometh- tate or elongate regions with sharply defined edges. 
acin appear to differ in several respects. First, the maxi- Microscopic examination of hematoxylin and eosin 
mum response to aspirin is more than twice that for stained paraffin sections taken from regions of ulcer- 
minor 'lceration '1' Increasing the dose to 2o the drugs, except at the highest dosage tested. This 
For the experiment, were 
Of the first 
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ation revealed necrosis of the gastric mucosa sometimes expected from the resultsof the first experiment, proba- 
extending to, but never through, the muscularis mucosa. bly reflecting monthly variations to susceptibility to 
In stressed animals, high doses of aspirin (I 80 gastric ulceration [Wilson, T. R., Monthly Variations in 
mgkg) produce very large ulcers (see FIG. Ib, Brown the Severity of Experimental Stress Ulcers in Rats. In 
et a]., 1976) generally not seen with very high doses 5 C .  J. Pfeiffer (Ed.) Peptic Ulcer, Philadelphia: J. C. 
(224  mg&) of hdomethacin. However, at lower Lippincott, 19711. At the lowest dose of pyrilamine 
doses, for a given mean ulcer score, the size as Well as administered, the mean ulcer score was reduced 38%. 
the regional distribution Of the Ulcers were similar for Similarly the lowest dose of metiamide reduced the 
aspirin and indomethacin. At the doses selected, both mean ulcer Score 24%. Increasing the dose of both 
agents produced numerOUS Small ulcers in the range Of 10 antihistamines produced further reductions in ulcer 
'Icers 3*0 mm Or severity resulting in a mean score of 10.1 and 11.2 for 
larger. Following the scoring method of Tagaki et al. and metiamide, respectively. The dose- 
[Chemical and Pharmaceutical Bulletin, 1964, 12, pages response relationship for these antihistamines was 
465 to 4721, the number of ulcers in each of five zones of highly significant as tested by a one-way analysis of 
F=6.47; df=3,53; p<O.OOl; the stomach was determined. FIG. 3 shows the anatom- 15 variance (Pyrilamine: ical divisions of a stomach which for better visualization Metiamide: F=4.65; df=3,52; p<o.ol). ne was has been opened along the greater curvature and pinned roughly 35 pmol/kg for metiamide. out. As can be seen from the drawing, the stomach is 
divided into three main areas, Le., the rumen (ll), the 
body (W, and the antrum (131, with each area compris- 20 
to 2.9 mm and Only 
TABLE 3 
THE ANTIULCER EFFECTS OF METIAMIDE AND 
ing the anatomical divisions indicated (I, 11,111, IV, and 
V). The distribution of gastric ulcers observed is shown 
in the following table. Condition Mean f SEM 
25 IND +MET 14.3 f 2.5 69.0 TABLE 2 
REGIONAL DISTRIBUTION OF GASTRIC ULCERS IND f PROM 19.6 f 4.9 57.0 
PRODUCED BY ASPIRIN AND INDOMETHACIN IN 
STRESSED ANIMALS 
PROMETHAZINE ON INDOMETHACIN PRODUCED 
ULCERS IN STRESSED RATS 
% Reduction 
IND 46.2 f 6.8 
*t(lS,lS) = 4.25, p <  005 
**t(lS,lS) = 3.06, p<.005 
Mean Number of Ulcers 
Aspirin Indomethacin As can be seen further from Table 3, the Hi receptor 
30 antagonist, promethazine, achieved reductions in gas- 
I 0.0 0.0 tric ulceration that are comparable to those produced 
I1 23.5 12.3 by metiamide. The latter tests were carried out with 
111 1.6 2.5 high doses of antihistamine (80 pmol/kg) in stressed rats 
IV 15.0 18.0 receiving 6 mg/kg of indomethacin. 
V 0.9 1.3 35 
( I 2  mg/kg) (20 mg&) 
Zone of Stomach N = 8  N = 8  
EXAMPLE 4 
As can be seen in Table 2, neither indomethacin nor The procedure of ~~~~~l~ 3 was followed except 
aspirin caused ulcers in Zone 1, the rumen of the stom- that the antihistamine used to counteract the gastric 
ach, but both drugs induced numerous Ulcers in Zones effects of indomethacin was cimetidine. Indomethacin 
I1 and IV Of the body. On the other hand, few ulcers 40 was administered at the usual rate of 6 mg/kg while the 
were produced by either agent in Zone 111 ofthe body cimetidine dosages tested were 20 and 80 pmol/kg, 
eight stressed rats being used for each level of antihista- 
The mean ulcer score for the control group was de- In these tests to determine the effect of antihistamines 45 termined to be 49 with a decrease to 33 for the lower 
dosage and to 21 for the higher dosage of cimetidine. In 
other words, the mean ulcer score was reduced 32.6% 
at the lower dose of cimetidine administered, and 57% 
or Zone V, the antrum. 
EXAMPLE 3 mine. 
on ulceration caused by the combined action of indo- 
methacin and stress, animals again were assigned ran- 
domly to groups receiving either pyrilamine maleate or 
metiamide at the dosages indicated in FIGS. 4 and 5. 
Additionally each animal received 6 mg/kg of indo- 50 at the higher 
methacin. Both the antihistmine and the anti-inflamma- As the present results clearly demonstrate, a dramatic 
tory agent were delivered orally in the Same 2 ml of 
methycellulose solution. Thirty minutes after drug ad- 
ministration each animal was subjected to two hours of 
synergism Occurs between acute stress and moderate 
dosages of anti-inflammatory agents in the Production 
of gastric ulceration (FIGS. 1 and 2). The difference 
cold restraint. At the end of that stress period, all ani- 55 between the effects of aspirin and indomethacin cannot 
mals were sacrificed by decapitation and the stomachs be attributed, however, to any additional effects in 
were removed, pinned, and scored as in Example 1. plasma corticosterone levels. The results do indicate 
To determine whether the antiulcerogenic properties that the level of plasma corticosterone was greatly in- 
of pyrilamine is specific to that drug, other animals creased by the stress procedure, but neither anti-inflam- 
were treated in the same manner with a structurally 60 matory agent was found to produce any additional in- 
different H1 receptor blocker, promethazine. crease in corticosterone level. 
The effectiveness of the antihistamines in inhibiting As to the effect of antihistamines on gastric ulceration 
gastric ulceration produced by indomethacin in rats caused by a combination of anti-inflammatory agents 
under stress is shown in FIGS. 4 and 5, and in Table 3. and stress, it was rather surprising to discover that not 
As can be seen from the curves plotted, the dose- 65 only metiamide could reduce ulceration, but that the 
response curves for pyrilamine and metiamide are very Hi receptor antagonist, pyrilamine and promethazine, 
similar. In the absence of antihistamine, the mean ulcer also did. Earlier published data (Brown et al. 1976) 
score in both control groups was somewhat higher than showed that the latter drugs do not function in that 
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capacity with aspirin. These data suggest generally that antihistamine drug selected from the group consisting 
the mechanism Of action Of indomethacin differs, in an of metamide and cimetidine, said antihistamine drug 
unknown manner, from that of aspirin. being administered at the rate of about 0.2 to 1.5 g for 
Although the invention has been described in terms each o.025 to o.200 
of certain preferred embodiments, it is contemplated 5 2. A pharmaceutical composition for reducing gastric that the man skilled in the art may carry out modifica- 
tions that will remain within the spirit and the scope of ulceration caused by the administration of indometha- 
the following claims. cin to a mammal under stress, comprising indomethacin 
What is claimed is: and about 0.2 to 1.5 g of an antihistamine drug selected 
1. A process for reducing gastric ulceration caused by 10 from the group consisting of m e t h i d e  and cimetidine, 
for each 0.025 to 0.200 g dose of indomethacin. 
dose of indomethacin. 
the administration of indomethacin to a mammal under 
stress, which comprise administering to said mammal an *c ,jr ,jt >It *r 
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